MARKET

OPNT

OPNT

Opiant Pharms
NASDAQ

Real-time Quotes | Nasdaq Last Sale

9.47
+0.17
+1.83%
After Hours: 9.40 -0.07 -0.74% 17:51 07/10 EDT
OPEN
9.30
PREV CLOSE
9.30
HIGH
9.55
LOW
8.90
VOLUME
60.36K
TURNOVER
--
52 WEEK HIGH
18.23
52 WEEK LOW
8.05
MARKET CAP
40.32M
P/E (TTM)
4.563
1D
5D
1M
3M
1Y
5Y

Analyst Rating

Based on 2 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target

The average OPNT stock price target is 40.00 with a high estimate of 42.00 and a low estimate of 38.00.

EPS

OPNT News

More
Edited Transcript of OPNT earnings conference call or presentation 12-May-20 8:30pm GMT
Thomson Reuters StreetEvents · 07/01 00:08
Teva Wins Narcan Patent Battle Sending Its Biotech Rivals Plunging
Investor's Business Daily · 06/08 19:41
CHK, VAL, XSPA and EKSO among midday movers
Seeking Alpha - Article · 06/08 16:46
Why Emergent BioSolutions Shares Are Crashing Today
MotleyFool.com · 06/08 15:33
EBS, OPNT among premarket losers
Seeking Alpha - Article · 06/08 13:22
Teva Wins Court Ruling Against Opiant, Emergent Bio On Narcan Nasal Spray
SmarterAnalyst · 06/07 08:36
Teva prevails in Narcan patent dispute with Opiant
Seeking Alpha - Article · 06/06 15:22
Opiant Pharmaceuticals Statement on U.S. District Court Decision
GlobeNewswire · 06/06 02:37

Industry

Biotechnology & Medical Research
-0.39%
Pharmaceuticals & Medical Research
-0.32%

Hot Stocks

Symbol
Price
%Change

About OPNT

Opiant Pharmaceuticals, Inc. is a specialty pharmaceutical company developing medicines for addictions and drug overdose. The Company has developed NARCAN (naloxone hydrochloride) Nasal Spray, a treatment to reverse opioid overdose. The Company’s pipeline includes medicines in development for Opioid Overdose Reversal (OOR), Alcohol Use Disorder (AUD), Opioid Use Disorder (OUD), and Acute Cannabinoid Overdose (ACO). The Company also is focused on other treatment opportunities within the addiction and drug overdose field.
More

Webull offers kinds of Opiant Pharmaceuticals Inc stock information, including NASDAQ:OPNT real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, OPNT stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading OPNT stock methods without spending real money on the virtual paper trading platform.